Abiopharma

🔍 Intrator Michael N (Director)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 136,947 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F3
• Acquired 136,947 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | shares_owned_after: 136,947.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F4
• Holds 21,867,489 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 21,867,489.00 | Footnotes: F1, F1, F1
• Holds 4,576,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 4,576,000.00 | Footnotes: F1, F1, F1, F5
• Holds 2,290,320 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 2,290,320.00 | Footnotes: F1, F1, F1, F6
• Holds 22,803,124 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 22,803,124.00 | Footnotes: F1, F1, F1, F7
• Holds 365,200 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 365,200.00 | Footnotes: F1, F1, F1, F8

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported transaction represents a gift, for no consideration, of shares of the Issuer's Class B Common Stock, which is exempt from the short-swing profit rule of Section 16 of the Exchange Act, pursuant to Rule 16b-5.
• F3: The reported securities were directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.
• F4: The reported securities are directly held by PMI 2024 F&F GRAT Remainder Trust, an irrevocable trust with a third-party trustee, of which certain of the reporting person's immediate family members are beneficiaries. The reporting person has the power to remove and replace the trustee. The reporting person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest, if any.
• F5: The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F6: The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F7: The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.
• F8: The reported securities are directly held by the reporting person's spouse.